<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29617505</article-id><article-id pub-id-type="pmc">5873777</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0108</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of the Effects of Atorvastatin and Ischemic
Postconditioning Preventing on the Ischemia and Reperfusion Injury: Experimental
Study in Rats</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pontes</surname><given-names>Henrique Budib Dorsa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Pontes</surname><given-names>Jos&#x000e9; Carlos Dorsa Vieira</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>PhD</role></contrib><contrib contrib-type="author"><name><surname>de Azevedo Neto</surname><given-names>Euler</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>Vendas</surname><given-names>Giovanna Serra da Cruz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>Miranda</surname><given-names>Jo&#x000e3;o Victor Cunha</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>Dias</surname><given-names>Let&#x000ed;cia do Esp&#x000ed;rito Santos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>Oliva</surname><given-names>Jo&#x000e3;o Victor Dur&#x000e3;es Gomes</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>de Almeida</surname><given-names>Murilo Henrique Martins</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>Chaves</surname><given-names>Ian de Oliveira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>Sampaio</surname><given-names>Tricia Luna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MS</role></contrib><contrib contrib-type="author"><name><surname>dos Santos</surname><given-names>Carlos Henrique Marques</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PhD</role></contrib><contrib contrib-type="author"><name><surname>Dourado</surname><given-names>Doroty Mesquita</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Universidade Anhanguera (Uniderp), Campo Grande, MS, Brazil. </aff><aff id="aff2">
<label>2</label> Universidade Federal do Mato Grosso do Sul (UFMS), Campo Grande,
MS, Brazil. </aff><author-notes><corresp id="c1">Correspondence Address: Henrique Budib Dorsa Pontes, Universidade
Anhanguera (Uniderp) - Curso de Medicina, Rua Piratininga, 755 - Campo Grande,
MS, Brazil - Zip code: 79021-210. E-mail:
<email>henriquedorsa01@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Feb</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2018</year></pub-date><volume>33</volume><issue>1</issue><fpage>72</fpage><lpage>81</lpage><history><date date-type="received"><day>02</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>16</day><month>10</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Reperfusion injury leads to systemic morphological and functional
pathological alterations. Some techniques are already estabilished to
attenuate the damage induced by reperfusion. Ischemic preconditioning is one
of the standard procedures. In the last 20 years, several experimental
trials demonstrated that the ischemic postconditioning presents similar
effectiveness. Recently experimental trials demonstrated that statins could
be used as pharmacological preconditioning.</p></sec><sec><title>Methods</title><p>41 Wistar rats (<italic>Rattus norvegicus albinus</italic>) were distributed
in 5 groups: Ischemia and Reperfusion (A), Ischemic Postconditioning (B),
Statin (C), Ischemic Postconditioning + Statins (D) and SHAM (E). After
euthanasia, lungs, liver, kidneys and ileum were resected and submitted to
histopathological analysis.</p></sec><sec><title>Results</title><p>The average of lung parenchymal injury was A=3.6, B=1.6, C=1.2, D=1.2, E=1
(<italic>P</italic>=0.0029). The average of liver parenchymal injury was
A=3, B=1.5, C=1.2, D=1.2, E = 0 (<italic>P</italic>&#x0003c;0.0001). The average
of renal parenchymal injury was A=4, B=2.44, C=1.22, D=1.11, E=1
(<italic>P</italic>&#x0003c;0.0001). The average of intestinal parenchymal
injury was A=2, B=0.66, C=0, D=0, E=0 (<italic>P</italic>=0.0006). The
results were submitted to statistics applying Kruskal-Wallis test,
estabilishing level of significance <italic>P</italic>&#x0003c;0.05.</p></sec><sec><title>Conclusion</title><p>Groups submitted to ischemic postconditioning, to pre-treatment with statins
and both methods associated demonstrated less remote reperfusion injuries,
compared to the group submitted to ischemia and reperfusion without
protection.</p></sec></abstract><kwd-group><kwd>Reperfusion Injury/Prevention &#x00026; Control</kwd><kwd>Hydroxymethylglutaryl-CoA</kwd><kwd>Oxidative Stress</kwd><kwd>Ischemic Postconditioning</kwd><kwd>Rats, Wistar</kwd></kwd-group></article-meta></front><body><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="43%" span="1"/><col width="3%" span="1"/><col width="5%" span="1"/><col width="43%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="2" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ADP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Adenosine
diphosphate</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HMG-CoA reductase</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">=
3-hydroxy-3-methylglutaryl-coenzyme A reductase</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ALT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Alanine
transaminase</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IL-1</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Interleukin-1</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AST</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Aspartate
transaminase</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IL-6</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Interleukin-6</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ATP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Adenosine
triphosphate</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">mRNA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Messenger ribonucleic
acid</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">cAMP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cyclic adenosine
monophosphate</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NADPH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Nicotinamide adenine
dinucleotide phosphate</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">eNOS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Endothelial nitric oxide
synthase</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Nitric oxide</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EROs</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Reactive species of
oxygen</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OONO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Peroxynitrite</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ET-1</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Endothelin-1</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ROS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Reactive oxygen
species</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">FPP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Farnesyl
pyrophosphate</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TNF-alpha</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Tumor necrosis factor
alpha</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">GGPP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Geranylgeranyl
pyrophosphate</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><sec><title>Ischemia and Reperfusion Lesion, Inflammation and Oxidative Stress</title><p>In an experimental study in rats in 1986, Parks and Granger<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup> demonstrated that the
mucosal injury membrane was more severe in rats submitted to 3 hours of ischemia
followed by 1 hour of reperfusion than that produced by exclusive ischemia for 4
hours. Since then, it has been proposed that reperfusion has more damaging
effects on cellular structures than ischemia itself. This event was called
ischemia and reperfusion injury.</p><p>The ischemia and reperfusion injury has its mechanisms closely related to the
inflammatory response and the production of reactive oxygen species (ROS).
During the ischemic period, the cell enters in an anaerobic metabolism, and the
oxidative phosphorylation of the mitochondria does not occur, so glycolysis
assumes the leading role in the production of adenosine triphosphate (ATP), but
it is not enough. During ischemia, ATP degradation in adenosine diphosphate
(ADP), cyclic adenosine monophosphate (cAMP), adenosine, inosine and finally the
accumulation of hypoxanthine occurs, which during reperfusion enhances ROS
production by the enzyme xanthine oxidase. The lower availability of ATP leads
to changes in the ATP-dependent ion exchange pumps, leading to intracellular
accumulation of sodium and ultimately to cell swelling and the entry of calcium
ions. The calcium entry into the intracellular medium leads to cytoskeleton
contraction, activation of phospholipase A2, and release of arachidonic acid and
its metabolites. From the degradation of the arachidonic acid products,
pro-inflammatory mediators, such as prostaglandins, leukotrienes and troboxanes,
which activate neutrophil adhesion and infiltration, and platelet aggregation,
are activated. Once in the tissues, neutrophils produce large amounts of ROS
leading to oxidative stress<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>The ROS overload leads to a decrease in nitric oxide (NO) bioavailability,
reacting with NO leading to the production of peroxynitrite (OONO-), a potent
oxygen-reactive species, highly damaging to cells. Decreased availability of NO
leads to a redistribution in circulation during the reperfusion period, the
socalled non-reflux phenomenon, leading to tissue damage. During the ischemia
and reperfusion injury, massive quantities of proinflammatory mediators such as
tumor necrosis factor alpha (TNFalpha), interleukin-1 (IL-1) and interleukin-6
(IL-6) are released into the bloodstream, leading to neutrophilic activation and
amplification of the pro-inflammatory response at the systemic level, thus
reaching organs that were not submitted to direct ischemia and could lead to
multiple organ dysfunction syndrome<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup> (<xref ref-type="fig" rid="f1">Figure
1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Mechanism of ischemia-reperfusion and oxidative stress.</p><p>I/R=ischemia/reperfusion, ADP=adenosine diphosphate; AMP=adenosine
monophosphate; ATP=adenosine triphosphate; IL-1=Interleukin-1;
IL-6=Interleukin-6; NO=nitric oxide; OONO-=Peroxynitrite;
ROS=reactive oxygen species; TNF-&#x003b1;=tumor necrosis factor
alpha</p></caption><graphic xlink:href="rbccv-33-01-0072-g01"/></fig>
</p></sec><sec><title>Ischemic Preconditioning and Ischemic Postconditioning</title><p>From the discovery of the ischemia and reperfusion injury, several methods were
proposed to try to attenuate the lesion during reperfusion. Murry et
al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>,
in 1986, proposed the ischemic preconditioning method, which consists of
subjecting a tissue to short cycles of ischemia and reperfusion before
submitting it to a prolonged time of ischemia, demonstrating the benefit of this
technique in rats isolated arteries. However, it is not always possible to apply
this technique, since in some conditions - such as pulmonary thromboembolism,
mesenteric ischemia and acute myocardial infarction - ischemia is already
present. For this purpose, the technique of ischemic postconditioning was
proposed, which consists in subjecting the tissue to short cycles of reperfusion
and ischemia after the period of ischemia and before subjecting it to
reperfusion for a prolonged period. Santos et al.<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> demonstrated that the
efficacy of this method is similar to the efficacy of ischemic preconditioning,
and there is no statistically significant difference between the two. This
technique is also able to protect tissues at a distance and can be applied in
arteries distal to the primary ischemic process, which is effective as
demonstrated by Dorsa et al.<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>, and was thus called remote postconditioning.</p><p>Since the discovery of the methods of minimization of ischemia and reperfusion
injury and its involvement with oxidative stress, alternatives to drug use, the
so-called pharmacological conditioning, are sought, with the advantage of not
manipulating vessels, thus being non-invasive. Among the drugs capable of
producing this effect, antioxidants and immunomodulators stand out.</p></sec><sec><title>Statins as Potential Anti-Inflammatory and Modulation of Oxidative
Stress</title><p>Statins are drugs widely used around the world. It is estimated that about 30
million people use some statin. This medication is used as an antidislipidemic,
and its mechanism of action is to inhibit the enzyme
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), a key
enzyme in liver cholesterol biosynthesis responsible for catalyzing the
reduction of HMG-CoA in mevalonate<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>However, statins seem to exert independent effects of cholesterol, called
pleiotropic effects. By inhibiting the conversion of HMG-CoA to L-mevalonate,
statins prevent the synthesis of isoprenoids, which are precursors of
cholesterol biosynthesis, which serve as important lipid ligands for
post-translational modification of intracellular proteins, in particular
farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), which are
responsible for the isoprenylation of wide-range OS proteins as small proteins
associate with guanosine triphosphate such Rho, Rac and Ras GTPases. This
protein isoprenylation allows adequate subcellular localization and
intracellular trafficking of proteins, which control various cellular functions,
and the inhibition of these pathways may determine important components of the
pleiotropic effects of statins. The Rho protein pathway is related to oxidative
stress, atherosclerosis and elevated blood pressure. The Rac protein pathway
signaling is involved in two crucial mechanisms, such as cytoskeletal remodeling
and ROS synthesis. Regarding the production of reactive species of oxygen
(EROs), Rac1 binds to p67phox leading to the activation of the nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase system, and subsequent generation
of EROs. In addition, inflammatory cytokines are mediated by
Rac<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>
(<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Action mechanism of the statins.</p></caption><graphic xlink:href="rbccv-33-01-0072-g02"/></fig>
</p><p>Statins also appear to improve endothelial function by both cholesterol-dependent
and cholesterol-independent mechanisms. Some studies have shown an improvement
in endothelial function independent of the reduction of serum cholesterol
levels<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>Statins increase endothelial nitric oxide synthase (eNOS) expression, more by
prolonging the half-life of messenger ribonucleic acid (mRNA) than by induction
of eNOS gene transcription, which under conditions of oxidative stress can
become uncoupled and produce O2 instead of NO contribuiting for endotelial
disfunction. Another important effect is the reduction of the abundance of
caveolin-1, an eNOS binding protein, which directly inhibits NO production, thus
increasing the availability of this vasodilator. Statins also demonstrated the
ability to increase the expression of T-PA and inhibition of endothelin-1 (ET-1)
expression<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. These mechanisms suggest that inhibition of these
intermediary pathways may contribute to the pleiotropic effects of statins,
minimizing ROS production and improving vascular and endothelial
function<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>This work was carried out in order to achieve responses regarding the efficacy of
statin in minimizing or even preventing ischemia and remote reperfusion injury
compared to the established ischemic postconditioning method and the efficacy of
these associated methods.</p></sec></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Animals</title><p>An experimental study was carried out in rats at the laboratory of the Agrarian
campus at Universidade Anhanguera (Uniderp) in the city of Campo Grande, MS,
Brazil, from April 2015 to November 2016.</p><p>Were used 41 male Norvergic Wistar rats, weighing 250 g-300 g, coming from
Hospital Veterin&#x000e1;rio da Uniderp. The animals were kept in cages measuring
40 cm x 33 cm and 17 cm depth, with four rats per cage, at an ambient
temperature of approximately 23&#x000ba;C, with light cycles of 12 h and fed with
Nuvital<sup>(r)</sup> feed and water <italic>ad libitum</italic>. The
research was authorized by the Ethical Committee on the Use of Animals of
Anhanguera Educacional Ltda. - CEUA/AESA for the 2996 sight.</p></sec><sec><title>Groups</title><p>The animals were distributed in the following groups:</p><p>
<list list-type="bullet"><list-item><p>Group A - Ischemia and Reperfusion: nine rats were submitted to
intestinal ischemia for 70 minutes by aortic clamping, followed by
reperfusion for 70 minutes;</p></list-item><list-item><p>Group B - Ischemic postconditioning: nine rats were submitted to the
ischemia procedure for 70 minutes by aortic clamping and reperfusion
for 70 minutes. Between ischemia and reperfusion, four cycles of
reperfusion (30 seconds each) were performed, interspersed with four
cycles of ischemia (30 seconds each);</p></list-item><list-item><p>Group C - Ischemic postconditioning + Statin: nine rats received a
dose of 3.4 mg/day of atorvastatin, one dose per day through the
gavage method, for seven days and underwent the ischemia procedure
for 70 minutes per aortic clamping and reperfusion for 70 minutes.
Between ischemia and reperfusion, four cycles of reperfusion (30
seconds each) were performed, interspersed with four cycles of
ischemia (30 seconds each);</p></list-item><list-item><p>Group D - Statin: nine rats received a dose of 3.4 mg/day
atorvastatin, one dose per day through the gavage method, for seven
days and underwent the ischemia procedure for 70 minutes by aortic
clamping and reperfusion for 70 minutes;</p></list-item><list-item><p>Group E - SHAM: five rats submitted only to laparotomy and
manipulation of the abdominal aorta.</p></list-item></list>
</p></sec><sec><title>Anesthesia</title><p>The anesthesic procedure used in the experiment was an intraperitoneal injection
of 2:1 solution with ketamine hydrochloride (Cetamin<sup>(r)</sup>), 50 mg/mL,
and xylazine hydrochloride (Xilazin<sup>(r)</sup>), 20 mg/mL, respectively, at
the dose of 0.1 mL/100 g)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>.</p></sec><sec><title>Surgical Procedure</title><p>The rats were submitted to a median longitudinal laparotomy of approximately 4
cm, exteriorization of the small intestine, identification and dissection of the
abdominal aorta.</p><p>In all groups except SHAM, the abdominal aorta was occluded by atraumatic
vascular clamp that remained for 70 minutes (ischemia phase).</p><p>After clamp placement, the small intestine was repositioned into the abdominal
cavity and the surgical wound was closed with continuous skin suture with 4-0
monofilament nylon (Mononylon<sup>(r)</sup>) yarn.</p><p>After the ischemia phase, the abdominal wall was reopened by removal of the
suture and in groups A and D, the vascular clamp was removed, initiating the
reperfusion phase, with a duration of 70 minutes. In groups B and C, preceding
the reperfusion phase, the ischemic postconditioning was performed through four
cycles of reperfusion (removal of the atraumatic vascular clamp from the
abdominal aorta) with duration of 30 seconds each, interspersed with four cycles
of ischemia (occlusion of the abdominal aorta artery by atraumatic vascular
clamp), also with duration of 30 seconds each.</p><p>In all groups after the start of the reperfusion phase, the abdomen was again
closed by continuous suturing of the skin with 4-0 monofilament nylon suture
until the end of the experiment.</p><p>In group E (SHAM), only the median longitudinal laparotomy of approximately 4 cm
was performed, with exteriorization of the small intestine, identification and
dissection of the abdominal aorta.</p><p>After reperfusion phase, in groups A, B and C, animals of all groups underwent
median thoracotomy and resection of the inferior lobe of the right lung and a
segment of approximately 1 cm of the ileum, 5 cm proximal to the ileocecal
transition, which was opened at its antimesenteric border; partial hepatectomy,
covering the median and left liver lobes and total withdrawal of the direct
kidney. After the procedure, all organs were washed with saline solution and
placed in 10% formaldehyde solution for further histological analysis.</p></sec><sec><title>Euthanasia</title><p>The euthanasia of the animals used in the experiments was by intraperitoneal
administration of lethal dose of anesthetic hydrochloride ketamine + xylazine
(0,4 mL per 100 g).</p></sec><sec><title>Histopathological Study</title><p>The specimens were kept for 48 hours in formaldehyde solution, after which they
were subjected to paraffin inclusion and cut into the micrometer to obtain the
histological slides. All slides were stained with hematoxylin-eosin (general
morphology of the organs) and analyzed by the pathologist under optical
microscopy, without previous knowledge about the group belonging to each
rat.</p><p>The pulmonary segments were classified according the degree of tissue injury from
Greca et al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>
(<xref ref-type="fig" rid="f3">Figure 3</xref>):</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Histopathological analysis of lung, kidney, liver and intestine.</p></caption><graphic xlink:href="rbccv-33-01-0072-g03"/></fig>
</p><p>
<list list-type="bullet"><list-item><p>Level 1 (normal): normal parenchyma under optical microscopy;</p></list-item><list-item><p>Level 2 (mild): focal edema in few alveolar septum, mild congestion,
neutrophils in alveolar septum in less than 50 per large increase
field;</p></list-item><list-item><p>Level 3 (moderate): moderate edema in alveolar septum or mild edema
in several septum, moderate congestion, neutrophils in alveolar
septum between 50 and 100 per large increase field;</p></list-item><list-item><p>Level 4 (severe): severe edema in alveolar septum or mild edema in
several septum, moderate congestion, neutrophils in alveolar septum
more than 100 per field.</p></list-item></list>
</p><p>The right kidney was analyzed according to the presence of tubular necrosis,
hydropic degeneration, medullary congestion, dilatation and tubular atrophy,
following the scale developed by Shih et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>, who considered (<xref ref-type="fig" rid="f3">Figure 3</xref>):</p><p>
<list list-type="bullet"><list-item><p>Level 0 = normal kidney;</p></list-item><list-item><p>Level 0.5 = small focal areas;</p></list-item><list-item><p>Level 1 = involvement of less than 10% of the renal cortex;</p></list-item><list-item><p>Level 2 = involvement of 10-25% of the renal cortex;</p></list-item><list-item><p>Level 3 = involvement of 25-75% of the renal cortex;</p></list-item><list-item><p>Level 4 = involvement of more than 75% of the renal cortex.</p></list-item></list>
</p><p>The hepatic tissues were evaluated and quantified the ischemia and reperfusion
injuries on the following histological characteristics: vascular congestion
(sinusoidal, centrolobular and portal space), necrosis and hepatic
steatosis.</p><p>The intensity of the histopathological features were expressed in crosses (0+ to
3+), obtained through the average of three random microscopic fields, being
evaluated in a 200fold increase, considering the following graduation described
by Rhoden et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> (<xref ref-type="fig" rid="f3">Figure
3</xref>):</p><p>
<list list-type="bullet"><list-item><p>Level 0+: absence of changes.</p></list-item><list-item><p>Level 1+ = changes of mild intensity (less than 25% of the field
analyzed);</p></list-item><list-item><p>Level 2+ = changes of moderate intensity (25 to 50% of the field
analyzed);</p></list-item><list-item><p>Level 3+ = changes of severe intensity (more than 50% of the analyzed
field).</p></list-item></list>
</p><p>The intestinal segments were classified according to degree of tissue injury from
Chiu et al.<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>:</p><p>
<list list-type="bullet"><list-item><p>Level 0 = mucous membrane without changes;</p></list-item><list-item><p>Level 1 = well-constituted villi, without cell lysis or inflammatory
process, but with formation of the Grunhagen subepithelial
space;</p></list-item><list-item><p>Level 2 = presence of cell lysis, formation of Grunhagen
subepithelial space and increased spacing between the villi;</p></list-item><list-item><p>Level 3 = destruction of the free portion of the villi, presence of
dilated capillaries and inflammatory cells;</p></list-item><list-item><p>Level 4 = structural destruction of the villi, with only a few
sketches, consisting of inflammatory cells and necrotic material,
with hemorrhage and basal glandular ulceration;</p></list-item><list-item><p>Level 5 = destruction of all mucous membrane, no more glandular
structure, but only amorphous material deposited on the submucosal
screen.</p></list-item></list>
</p></sec><sec><title>Statistical Analysis</title><p>The results were submitted to statistical analysis, applying the Kruskal-Wallis
test, establishing the level of significance of <italic>P</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Histopathological Analysis of the Lungs</title><p>The histopathological analysis of the pulmonary parenchyma specimens, according
to Greca et al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>, showed mean values of 3.6 in group A; 1.6 in group
B; 1.2 in groups C and D and 1 in group E (<xref ref-type="table" rid="t1">Table
1</xref> and <xref ref-type="fig" rid="f4">Figure 4</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Results of statistic analysis of tissue injuries.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><tbody><tr style="border-top:hidden"><td align="left" colspan="6" rowspan="1"><bold>Histopathological classification
of lung parenchyma injury in rats</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Rats</bold></td><td align="center" rowspan="1" colspan="1"><bold>A</bold></td><td align="center" rowspan="1" colspan="1"><bold>B</bold></td><td align="center" rowspan="1" colspan="1"><bold>C</bold></td><td align="center" rowspan="1" colspan="1"><bold>D</bold></td><td align="center" rowspan="1" colspan="1"><bold>E</bold></td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">AVERAGE</td><td align="center" rowspan="1" colspan="1">3.6</td><td align="center" rowspan="1" colspan="1">1.6</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr style="border-bottom:hidden"><td align="left" colspan="6" rowspan="1"><italic>P</italic>=0.0029
(Kruskal-Wallis)</td></tr><tr><td align="left" colspan="6" rowspan="1"><bold>Histopathological classification
of liver parenchyma injury in rats</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Rats</bold></td><td align="center" rowspan="1" colspan="1"><bold>A</bold></td><td align="center" rowspan="1" colspan="1"><bold>B</bold></td><td align="center" rowspan="1" colspan="1"><bold>C</bold></td><td align="center" rowspan="1" colspan="1"><bold>D</bold></td><td align="center" rowspan="1" colspan="1"><bold>E</bold></td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">AVERAGE</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr style="border-bottom:hidden"><td align="left" colspan="6" rowspan="1"><italic>P</italic>&#x0003c;0.0001
(Kruskal-Wallis)</td></tr><tr><td align="left" colspan="6" rowspan="1"><bold>Histopathological classification
of intestinal parenchyma injury in rats</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Rats</bold></td><td align="center" rowspan="1" colspan="1"><bold>A</bold></td><td align="center" rowspan="1" colspan="1"><bold>B</bold></td><td align="center" rowspan="1" colspan="1"><bold>C</bold></td><td align="center" rowspan="1" colspan="1"><bold>D</bold></td><td align="center" rowspan="1" colspan="1"><bold>E</bold></td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">AVERAGE</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.66</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr style="border-bottom:hidden"><td align="left" colspan="6" rowspan="1"><italic>P</italic>=0.0006
(Kruskal-Wallis)</td></tr><tr><td align="left" colspan="6" rowspan="1"><bold>Histopathological classification
of renal parenchyma injury in rats</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Rats</bold></td><td align="center" rowspan="1" colspan="1"><bold>A</bold></td><td align="center" rowspan="1" colspan="1"><bold>B</bold></td><td align="center" rowspan="1" colspan="1"><bold>C</bold></td><td align="center" rowspan="1" colspan="1"><bold>D</bold></td><td align="center" rowspan="1" colspan="1"><bold>E</bold></td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;-</td></tr><tr><td align="center" rowspan="1" colspan="1">AVERAGE</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2.44</td><td align="center" rowspan="1" colspan="1">1.22</td><td align="center" rowspan="1" colspan="1">1.11</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr style="border-bottom:hidden"><td align="left" colspan="6" rowspan="1"><italic>P</italic>=0.0001
(Kruskal-Wallis)</td></tr></tbody></table></table-wrap><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Graphics analyzing the level of injury among tissues in each
organ.</p></caption><graphic xlink:href="rbccv-33-01-0072-g04"/></fig>
</p></sec><sec><title>Histopathological Analysis of the Kidney</title><p>In the histopathological analysis of the kidney specimens, a mean degree of
injury 4 was found in group A, meaning involvement of more than 75% of the renal
cortex; group B obtained a mean of 2.44; C group obtained a mean of 1.22 and in
group D the mean D was 1.11. Group E obtained mean 1 (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f4">Figure
4</xref>).</p></sec><sec><title>Histopathological Analysis of the Liver</title><p>Among the histopathological analysis of the liver was used the classification of
Rhoden et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> on the 41 slides.</p><p>It was concluded from the analysis that group A obtained a 3+ mean of injury,
being considered intense alterations; group B obtained a mean of 1.5+; groups C
and D obtained the same means of degree of injury: 1.2 + (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f4">Figure
4</xref>).</p></sec><sec><title>Histopathological Analysis of Intestin</title><p>In the analysis of the intestine slides, pathological changes were observed in
group A of ischemia and reperfusion and a protective action of the
treatments.</p><p>Group A, that underwent ischemia/reperfusion, obtained average degree of injury
2; group B associated with ischemic postconditioning obtained a mean of 0.66.
The other groups, C, D and E, obtained degree 0 of injuries, which means that
there were no alterations (<xref ref-type="table" rid="t1">Table 1</xref> and
<xref ref-type="fig" rid="f4">Figure 4</xref>).</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In recent years, research on oxidative stress has been increasingly important because
it is the inflammatory pathophysiological mechanism that determines many chronic
degenerative diseases, such as heart failure, central nervous system diseases,
oncogenetics, among others, and acute events with a high rate of mortality, such as
multiple organ dysfunction syndrome<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>Thirty years have passed since Murry et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> proposed the technique of ischemic
preconditioning. Because it is a procedure with limitations, due to the
impossibility of employing it in several situations, justified by the fact that
ischemia is already installed, new alternatives were sought, among them ischemic
postconditioning.</p><p>In several clinical situations, it is not possible to use any method, since the organ
artery is not accessible. Brief episodes of ischemia/ reperfusion were applied to
remote tissues, such as small intestine, kidney, liver and even lower limbs, and
demonstrated to reduce infarct size in hearts submitted to coronary occlusion,
followed by reperfusion - a technique called remote preconditioning.</p><p>Dorsa et al.<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>, in a
study involving 3 groups of rats, one control group, and two groups submitted to
ischemia/reperfusion by abdominal aorta clamping, in one of which the remote
postconditioning technique was used. As in the present study, these researchers used
Greca et al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>
classification to evaluate the degree of lung parenchymal injury. The result
obtained in the Dorsa's study is very similar to the result of the present study,
since the mean of the degree of lung injury was 1.3 and in this study was 1.6 when
it refers to the post-ischemic conditioning<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>In a work carried out by Naidu et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, mice were treated with simvastatin for five days,
lungs submitted to ischemia for 90 minutes and reperfusion for 4 hours,
demonstrating a 71% reduction in pulmonary vascular permeability when compared to
the untreated group. In addition, there was a 68% reduction of tissue
myeloperoxidase and reduction of leukocyte accumulation in bronchoalveolar lavage.
In the present study, the group treated with atorvastatin for seven days presented
preservation of the pulmonary parenchyma, absence of hemorrhagic focus, congested
blood vessels, necrosis, neutrophil accumulation and focal edema. It presented only
inflammatory focus, showing a significant reduction of the lesion in comparison to
group A (positive control), whose grade was 3.6. According to Greca et
al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>, in
the present study, the degree of injury in groups C (atorvastatin only) and D
(atorvastatin and ischemic postconditioning) was 1.2 in both groups.</p><p>In the study by Sun et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, in rats submitted to lower limb ischemia for two
hours, followed by three hours of reperfusion, the groups receiving statin
pretreatment for three days also demonstrated reduction of myeloperoxidase and
malondialdehyde levels in tissues, neutrophil accumulation and significant decrease
in lung parenchymal lesions compared to the group that underwent ischemia and
reperfusion without previous treatment, according to the histopathological findings
of the present study<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>.</p><p>The literature does not have yet works involving the histological analysis of the use
of remote postconditioning in the prevention of ischemia/reperfusion injury at a
distance, especially in organs used in the present study, such as liver and
kidney.</p><p>Seifi et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>
studied the degree of hepatic impairment in three groups of rats: a control group, a
group submitted to ischemia/reperfusion of the left renal artery and one group
submitted to ischemia/reperfusion and protected by remote ischemic postconditioning
performed in the left renal artery. The results were analyzed by the biochemical
assay and by the measurement of oxidative stress markers. The postconditioned group
showed a significant decrease in alanine transaminase (ALT) and aspartate
transaminase (AST) liver injury enzymes in relation to the ischemia/reperfusion
group, and a lower dosage of malondialdehyde<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. In the present study, remote
postconditioning also had a protective effect on the hepatic parenchyma, with the
mean degree of injury 1.5+ according to Rhoden et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>, and in contrast to the
mean of 3+ in the group submitted to ischemia/reperfusion alone.</p><p>In the experimental research carried out by Lai et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>, the group in which
pharmacological preconditioning was performed with intraperitoneal simvastatin
demonstrated a significant reduction in the levels of liver injury enzymes, ALT and
AST, and reduction of apoptosis of hepatocyte, compared to the group submitted to
ischemia/reperfusion of the liver without treatment. In the present study, we
observed reduction of vascular congestion, vessel thickening, necrosis and apoptosis
of hepatocytes and tissue, centrolobular edema. Quantitatively, the degree of
injury, according to Rhoden et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>, of the group undergoing pretreatment with
atorvastatin presented the mean of 1.2, contrasting with the mean of 3 of group A
(positive control). The group that was associated with atorvastatin with ischemic
postconditioning presented the same protection and the same mean of the degree of
injury of 1.2.</p><p>The literature does not yet have experimental work that tests the pretreatment with
statin in the remote ischemia/reperfusion lesion, and studies that use the
histopathological analysis to quantify the degree of injury and the protection
capacity of this method. For this reason, the results found in the present study
cannot be adequately compared. However, in the studies already published and in the
present study, statin has been shown to be a promising drug in the prevention of
ischemia and reperfusion injury and in acute oxidative stress.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The groups submitted to postconditioning, pretreatment with statins and the two
associated methods (groups B, D and C, respectively) showed a lower degree of
ischemia and a remote reperfusion injury compared to the group submitted to I/R
injury without protection (group A), and the groups treated with statins showed
slightly better results than the postconditioning group. Further studies regarding
the use of statins and postconditioning should be performed to elucidate its
mechanisms and ratify its effectiveness in the prevention and minimization of
ischemia and reperfusion lesions.</p><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">HBDP</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">JCDVP</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis; final approval of the
version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">EAN</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis; final approval of the
version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">GSCV</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately resolved; final approval of
the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">JVCM</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately and resolved; final approval
of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">LESD</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately and resolved; final approval
of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">JVDGO</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately and resolved; final approval
of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">MHMA</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately and resolved; final approval
of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">IOC</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately and resolved; final approval
of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">TLS</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately and resolved; final approval
of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">CHMS</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">DMD</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis; drafting the work or
revising it critically for important intellectual content; final
approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Universidade Anhanguera (Uniderp), Campo Grande,
MS, Brazil.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>DA</given-names></name><name><surname>Granger</surname><given-names>DN</given-names></name></person-group><article-title>Contributions of ischemia and reperfusion to mucosal lesion
formation</article-title><source>Am J Physiol</source><year>1986</year><volume>250</volume><issue>6</issue><issue-part>1</issue-part><fpage>G749</fpage><lpage>G753</lpage><pub-id pub-id-type="pmid">3717337</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pontes</surname><given-names>HBD</given-names></name><name><surname>Azevedo Neto</surname><given-names>E</given-names></name><name><surname>Pontes</surname><given-names>JCDV</given-names></name><name><surname>Vendas</surname><given-names>GSC</given-names></name><name><surname>Miranda</surname><given-names>JVC</given-names></name><name><surname>Sampaio</surname><given-names>TL</given-names></name><etal/></person-group><article-title>Ischemia and reperfusion injury: general aspects and
mechanisms</article-title><source>EC Cardiology</source><year>2016</year><volume>2</volume><issue>5</issue><fpage>240</fpage><lpage>248</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murry</surname><given-names>CE</given-names></name><name><surname>Jenning</surname><given-names>RB</given-names></name><name><surname>Reimer</surname><given-names>KA</given-names></name></person-group><article-title>Preconditioning with ischemia: a delay of lethal cell injury in
ischemic myocardium</article-title><source>Circulation</source><year>1986</year><volume>74</volume><issue>5</issue><fpage>1124</fpage><lpage>1136</lpage><pub-id pub-id-type="pmid">3769170</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>CH</given-names></name><name><surname>Pontes</surname><given-names>JC</given-names></name><name><surname>Gomes</surname><given-names>OM</given-names></name><name><surname>Miiji</surname><given-names>LN</given-names></name><name><surname>Bispo</surname><given-names>MA</given-names></name></person-group><article-title>Evaluation of ischemic postconditioning effect on mesenteric
ischemia treatment: experimental study in rats</article-title><source>Rev Bras Cir Cardiovasc</source><year>2009</year><volume>24</volume><issue>2</issue><fpage>150</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">19768293</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorsa</surname><given-names>RC</given-names></name><name><surname>Pontes</surname><given-names>JC</given-names></name><name><surname>Antoniolli</surname><given-names>AC</given-names></name><name><surname>Silva</surname><given-names>GV</given-names></name><name><surname>Benfatti</surname><given-names>RA</given-names></name><name><surname>Santos</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Effect of remote ischemic postconditioning in inflammatory
changes of the lung parenchyma of rats submitted to ischemia and
reperfusion</article-title><source>Rev Bras Cir Cardiovasc</source><year>2015</year><volume>30</volume><issue>3</issue><fpage>353</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">26313726</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Istvan</surname><given-names>ES</given-names></name><name><surname>Deisenhofer</surname><given-names>J</given-names></name></person-group><article-title>Structural mechanism for statin inhibition of HMG-CoA
reductase</article-title><source>Science</source><year>2001</year><volume>292</volume><issue>5519</issue><fpage>1160</fpage><lpage>1164</lpage><pub-id pub-id-type="pmid">11349148</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaresan</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>ZX</given-names></name><name><surname>Ferrans</surname><given-names>VJ</given-names></name><name><surname>Sulciner</surname><given-names>DJ</given-names></name><name><surname>Gutkind</surname><given-names>JS</given-names></name><name><surname>Irani</surname><given-names>K</given-names></name><etal/></person-group><article-title>Regulation of reactive-oxygen-species generation in fibroblasts
by Rac1</article-title><source>Biochem J</source><year>1996</year><volume>318</volume><issue-part>2</issue-part><fpage>379</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">8809022</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>S</given-names></name><name><surname>Reina-Couto</surname><given-names>M</given-names></name><name><surname>Albino-Teixeira</surname><given-names>A</given-names></name><name><surname>Sousa</surname><given-names>T</given-names></name></person-group><article-title>Statins and oxidative stress in chronic heart
failure</article-title><source>Rev Port Cardiol</source><year>2016</year><volume>35</volume><issue>1</issue><fpage>41</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">26763895</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essig</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>G</given-names></name><name><surname>Pri&#x000e9;</surname><given-names>D</given-names></name><name><surname>Escoubet</surname><given-names>B</given-names></name><name><surname>Sraer</surname><given-names>JD</given-names></name><name><surname>Friedlander</surname><given-names>G</given-names></name></person-group><article-title>3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
increase fibrinolytic activity in rat aortic endothelial cells. Role of
geranylgeranylation and Rho proteins</article-title><source>Circ</source><year>1998</year><volume>83</volume><issue>7</issue><fpage>683</fpage><lpage>690</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Flecknell</surname><given-names>PA</given-names></name><name><surname>Richardson</surname><given-names>CA</given-names></name><name><surname>Popovic</surname><given-names>A</given-names></name></person-group><chapter-title>Laboratory animals</chapter-title><person-group person-group-type="editor"><name><surname>Tranquilli</surname><given-names>WJ</given-names></name><name><surname>Thurmon</surname><given-names>JC</given-names></name><name><surname>Grimm</surname><given-names>KA</given-names></name></person-group><source>Lumb and Jones' veterinary anesthesia and analgesia</source><edition>4th ed.</edition><publisher-loc>Ames</publisher-loc><publisher-name>Blackwell Publishing</publisher-name><year>2007</year><fpage>765</fpage><lpage>784</lpage></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greca</surname><given-names>FH</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>NMFM</given-names></name><name><surname>Souza Filho</surname><given-names>ZA</given-names></name><name><surname>Noronha</surname><given-names>L</given-names></name><name><surname>Silva</surname><given-names>RFKC</given-names></name><name><surname>Rubin</surname><given-names>MR</given-names></name></person-group><article-title>A influ&#x000ea;ncia do azul de metileno na
preven&#x000e7;&#x000e3;o da les&#x000e3;o pulmonar, intestinal e renal
ap&#x000f3;s isquemia-reperfus&#x000e3;o intestinal</article-title><source>Acta Cir Bras</source><year>2008</year><volume>23</volume><issue>2</issue><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">18372960</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>W</given-names></name><name><surname>Hines</surname><given-names>WH</given-names></name><name><surname>Neilson</surname><given-names>EG</given-names></name></person-group><article-title>Effects of cyclosporine A on the development of immune-mediated
interstitial nephritis</article-title><source>Kidney Int</source><year>1988</year><volume>33</volume><issue>6</issue><fpage>1113</fpage><lpage>1118</lpage><pub-id pub-id-type="pmid">3261370</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhoden</surname><given-names>EL</given-names></name><name><surname>Pereira-Lima</surname><given-names>L</given-names></name><name><surname>Rhoden</surname><given-names>CR</given-names></name><name><surname>Lucas</surname><given-names>ML</given-names></name><name><surname>Mauri</surname><given-names>M</given-names></name><name><surname>Zettler</surname><given-names>CG</given-names></name></person-group><article-title>An&#x000e1;lise das altera&#x000e7;&#x000f5;es
histopatol&#x000f3;gicas do f&#x000ed;gado de ratos pr&#x000e9;-tratados com
alopurinol e submetidos &#x000e0; isquemia: reperfus&#x000e3;o
hep&#x000e1;tica</article-title><source>Rev Col Bras Cir</source><year>2000</year><volume>27</volume><issue>6</issue><fpage>373</fpage><lpage>377</lpage></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>CJ</given-names></name><name><surname>McArdle</surname><given-names>AH</given-names></name><name><surname>Brown</surname><given-names>R</given-names></name><name><surname>Scott</surname><given-names>HJ</given-names></name><name><surname>Gurd</surname><given-names>FN</given-names></name></person-group><article-title>Intestinal mucosal lesion in low-flow states. I. A morphological,
hemodynamic, and metabolic reappraisal</article-title><source>Arch Surg</source><year>1970</year><volume>101</volume><issue>4</issue><fpage>478</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">5457245</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pontes</surname><given-names>HBD</given-names></name><name><surname>Pontes</surname><given-names>JCDV</given-names></name><name><surname>Azevedo Neto</surname><given-names>E</given-names></name><name><surname>Zangari</surname><given-names>AH</given-names></name><name><surname>Miranda</surname><given-names>JVC</given-names></name><name><surname>Gomes</surname><given-names>OM</given-names></name></person-group><article-title>Cardiac remodelling: general aspects and
mechanisms</article-title><source>Curr Res Cardiol</source><year>2016</year><volume>3</volume><issue>3</issue><fpage>79</fpage><lpage>82</lpage></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltowski</surname><given-names>J</given-names></name></person-group><article-title>Statins and modulation of oxidative stress</article-title><source>Toxicol Mech Methods</source><year>2005</year><volume>15</volume><issue>2</issue><fpage>61</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">20021068</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naidu</surname><given-names>BV</given-names></name><name><surname>Woolley</surname><given-names>SM</given-names></name><name><surname>Farivar</surname><given-names>AS</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Fraga</surname><given-names>C</given-names></name><name><surname>Mulligan</surname><given-names>MS</given-names></name></person-group><article-title>Simvastatin ameliorates injury in an experimental model of lung
ischemia-reperfusion</article-title><source>J Thorac Cardiovasc Surg</source><year>2003</year><volume>126</volume><issue>2</issue><fpage>482</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">12928648</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>XF</given-names></name><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Wang</surname><given-names>JK</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>BY</given-names></name><etal/></person-group><article-title>Effects of simvastatin on lung injury induced by
ischaemia-reperfusion of the hind limbs in rats</article-title><source>J Int Med Res</source><year>2007</year><volume>35</volume><issue>4</issue><fpage>523</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">17697530</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seifi</surname><given-names>B</given-names></name><name><surname>Kadkhodaee</surname><given-names>M</given-names></name><name><surname>Najafi</surname><given-names>A</given-names></name><name><surname>Mahmoudi</surname><given-names>A</given-names></name></person-group><article-title>Protection of liver as a remote organ after renal
ischemia-reperfusion injury by renal ischemic
postconditioning</article-title><source>Int J Nephrol</source><year>2014</year><volume>2014</volume><elocation-id>120391</elocation-id><pub-id pub-id-type="pmid">24744919</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>IR</given-names></name><name><surname>Chang</surname><given-names>KJ</given-names></name><name><surname>Chen</surname><given-names>CF</given-names></name></person-group><article-title>The mechanism of hepatic heme oxygenase-1 expression by limb
remote ischemic preconditioning</article-title><source>Transplantation</source><year>2007</year><volume>83</volume><issue>3</issue><fpage>364</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">17297416</pub-id></element-citation></ref></ref-list></back></article>